LPL Financial’s Sutro Biopharma STRO Stock Holding History

LPL Financial’s Portfolio STRO Stock Details STRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,000	Closed	-$13K	–	5676
2025 Q1	$13K	Buy	+2,000	New	+$31.5K	﹤0.01%	5296

Other funds holding STRO

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

LPL Financial's STRO Position: Q4 2025 in Review

LPL Financial sold out of Sutro Biopharma (STRO) in Q4 2025, closing a stake of 14,288 shares — an estimated $124K sold.

LPL Financial first reported a position in STRO in Q2 2024 and held it in 6 quarters. The position peaked at $934K in Q3 2024. 63 funds tracked by Wall St. Rank hold STRO as of Q4 2025.

LPL Financial reported no remaining Sutro Biopharma position as of Q4 2025 after selling out during the quarter.
LPL Financial sold 14,288 Sutro Biopharma shares in Q4 2025, an estimated $124K.
LPL Financial first reported a position in Sutro Biopharma in Q2 2024 and held it in 6 quarters.
LPL Financial's Sutro Biopharma position peaked at $934K in Q3 2024.
63 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2025.

Based on LPL Financial's 13F filing for Q4 2025, filed 11 Feb 2026.